Table 3.
Post-operative and clinical outcomes according to pre-sarcopenia status
| Non-pre-sarcopenia (N = 144) | Pre-sarcopenia (N = 72) | P | |
|---|---|---|---|
| Postoperative hospital days (median [IQR]) | 13.0 [10.0–17.0] | 14.0 [10.8–17.0] | 0.450 |
| Stent, yes (%) | 80 (55.6) | 37 (51.4) | 0.562 |
| Stoma, yes (%) | 25 (17.4) | 16 (22.2) | 0.390 |
| Emergency operation, yes (%) | 9 (6.3) | 6 (8.3) | 0.570 |
| Transfusion, yes (%) | 66 (45.8) | 41 (56.9) | 0.124 |
| Complications (%) | 0.906 | ||
| No | 119 (82.6) | 58 (80.6) | |
| Minora | 17 (11.8) | 9 (12.5) | |
| Majorb | 8 (5.6) | 5 (6.9) | |
| Anastomosis leak (%) | 7 (4.9) | 4 (5.6) | 0.827 |
| Postoperative ileus (%) | 8 (5.6) | 3 (4.2) | 0.662 |
| Surgical site infection (%) | 6 (4.2) | 2 (2.8) | 0.610 |
| Anastomosis site bleeding (%) | 2 (1.4) | 0 (0.0) | 0.315 |
| Urinary retention (%) | 2 (1.4) | 2 (2.8) | 0.475 |
| Atelectasis (%) | 4 (2.8) | 3 (4.2) | 0.587 |
| Pleural effusion | 1 (0.7) | 1 (1.4) | 0.615 |
| Asthma attack | 1 (0.7) | 0(0.0) | 0.478 |
| Recurrence, yes (%) | 30 (20.8) | 23 (31.9) | 0.074 |
| Death, yes (%) | 20 (13.9) | 21 (29.2) | 0.007 |
| Disease-free survival time (months) (median [IQR]) | 42.0 [24.0–133.0] | 29.5 [11.8–109.0] | 0.007 |
| Overall-survival time (months) (median [IQR]) | 58.0 [26.0–81.0] | 38.0 [21.8–60.3] | 0.047 |
aClavien-Dindo Classification < IIIb
bClavien-Dindo Classification ≥ IIIb